Skip to main content

and
  1. No Access

    Article

    A Japanese multi-institutional phase II study of moderate hypofractionated intensity-modulated radiotherapy with image-guided technique for prostate cancer

    The aim of this multi-institutional phase II study was to confirm the safety and the potential efficacy of moderately hypofractionated intensity-modulated radiotherapy (IMRT) with prostate-based image-guidance...

    Katsumasa Nakamura, Keiji Nihei in International Journal of Clinical Oncology (2024)

  2. No Access

    Article

    Evaluation of breast cosmetic changes with a computer-software; the breast cancer conservative treatment cosmetic results (BCCT. core) in hypofractionated whole breast irradiation after breast-conserving surgery-supplementary analysis of multicenter single-arm confirmatory trial: JCOG0906

    A good cosmetic outcome has been defined as an important endpoint in breast-conserving therapy (BCT). Various evaluation methods have been studied, but the optimal method has yet to be identified. The present ...

    Miwako Nozaki, Yoshikazu Kagami, Mitsuhiro Takahashi, Ryunosuke Machida in Breast Cancer (2022)

  3. Article

    Open Access

    Optimizing antiemetic treatment for chemotherapy-induced nausea and vomiting in Japan: Update summary of the 2015  Japan Society of Clinical Oncology Clinical Practice Guidelines for Antiemesis

    Patients with cancer should appropriately receive antiemetic therapies against chemotherapy-induced nausea and vomiting (CINV). Antiemetic guidelines play an important role in managing CINV. Accordingly, the f...

    Kenjiro Aogi, Hideki Takeuchi, Toshiaki Saeki in International Journal of Clinical Oncology (2021)

  4. Article

    Open Access

    Prospective study of postoperative whole breast radiotherapy for Japanese large-breasted women: a clinical and dosimetric comparisons between supine and prone positions and a dose measurement using a breast phantom

    This prospective study aimed to compare dose volume histograms (DVH) of the breasts and organs at risk (OARs) of whole breast radiotherapy in the supine and prone positions, and frequency and severity of acute...

    Kana Takahashi, Madoka Morota, Yoshikazu Kagami, Hiroyuki Okamoto in BMC Cancer (2016)

  5. Article

    Open Access

    Japanese Society of Clinical Oncology clinical practice guidelines 2010 for antiemesis in oncology: executive summary

    The purpose of this article is to disseminate the standard of antiemetic therapy for Japanese clinical oncologists. On the basis of the Appraisal of Guidelines for Research and Evaluation II instrument, which ...

    Hideki Takeuchi, Toshiaki Saeki, Keisuke Aiba in International Journal of Clinical Oncology (2016)

  6. No Access

    Article

    Dose calculation accuracies in whole breast radiotherapy treatment planning: a multi-institutional study

    Our objective in this study was to evaluate the variation in the doses delivered among institutions due to dose calculation inaccuracies in whole breast radiotherapy. We have developed practical procedures fo...

    Shogo Hatanaka, Yuki Miyabe, Naoki Tohyama in Radiological Physics and Technology (2015)

  7. No Access

    Article

    Locoregional recurrence risk factors and the impact of postmastectomy radiotherapy on patients with tumors 5 cm or larger

    Locoregional recurrence (LRR) after mastectomy reduces the patient’s quality of life and survival. There is a consensus that postmastectomy radiotherapy (PMRT) helps achieve locoregional control and reduces LR...

    Tomoya Nagao, Takayuki Kinoshita, Nobuko Tamura, Takashi Hojo in Breast Cancer (2014)

  8. No Access

    Article

    Locoregional recurrence risk factors in breast cancer patients with positive axillary lymph nodes and the impact of postmastectomy radiotherapy

    Locoregional recurrence (LRR) after mastectomy reduces the patient’s quality of life and survival. There is a consensus that postmastectomy radiotherapy (PMRT) helps establish locoregional control and reduces ...

    Tomoya Nagao, Takayuki Kinoshita in International Journal of Clinical Oncology (2013)

  9. No Access

    Article

    Palliative radiation therapy for hemorrhage of unresectable gastric cancer: a single institute experience

    To clarify the toxicity of palliative radiotherapy (RT) and its efficacy against bleeding of unresectable gastric cancer.

    Kenji Hashimoto, Hiroshi Mayahara in Journal of Cancer Research and Clinical On… (2009)

  10. No Access

    Article

    A phase I/II study of nedaplatin and 5-fluorouracil with concurrent radiotherapy in patients with T4 esophageal cancer: Japan Clinical Oncology Group trial (JCOG 9908)

    Nedaplatin is an analogue of cisplatin with less nonhematologic toxicity. The combination of nedaplatin and 5-fluorouracil showed a promising response rate in a previous phase II study for metastatic esophagea...

    Satoshi Ishikura, Atsushi Ohtsu, Kuniaki Shirao, Kei Muro, Yoshikazu Kagami in Esophagus (2005)

  11. No Access

    Article

    Primary Mediastinal Large B-Cell Lymphoma: A Single-Institution Clinical Study in Japan

    Several clinicopathologic studies of primary mediastinal large B-cell lymphoma (Med-DLBCL) have been reported from Western countries; however, only a few series of at most 10 cases are available in Japan.To fu...

    Naohiro Sekiguchi, Junko Nishimoto, Kazuki Tanimoto in International Journal of Hematology (2004)

  12. No Access

    Article

    Radiotherapy for Hepatocellular Carcinoma

    To retrospectively evaluate the effectiveness of radiotherapy with or without transarterial embolization (TAE) and/or percutaneous ethanol injection (PEI) in patients with hepatocellular carcinoma who were in...

    Koichi Tokuuye, Minako Sumi, Yoshikazu Kagami in Strahlentherapie und Onkologie (2000)

  13. No Access

    Article

    Clinical benefit response of concurrent chemoradiotherapy with protracted 5-fluorouracil infusion in patients with locally advanced pancreatic cancer

    Pancreatic cancer is a highly virulent disease with a poor prognosis. Although objective tumor response to chemotherapy and/or radiotherapy is low, some patients show an improvement in their symptoms after tre...

    Takuji Okusaka, Shuichi Okada, Hiroshi Ishii in International Journal of Clinical Oncology (1998)